Naba Alsaha Medical Services Company (9546.SR)
SAR 77.0
(-0.39%)
SAR 77.0
(-0.39%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 182.35 Million | 129.68 Million | 117.68 Million | 115.68 Million |
| Cost of Revenue | 108.58 Million | 78.04 Million | 70.89 Million | 69.75 Million |
| Gross Profit | 73.76 Million | 51.63 Million | 46.78 Million | 45.93 Million |
| Operating Expenses | 30.18 Million | 22.23 Million | 18.88 Million | 18.28 Million |
| Selling, General and Administrative Expenses | 30.18 Million | 4.38 Million | 4.75 Million | 18.28 Million |
| Research and Development Expenses | - | - | - | - |
| Other Expenses | - | 1.09 Million | - | - |
| Cost and Expenses | 139.38 Million | 100.27 Million | 89.78 Million | 88.03 Million |
| Operating Income | 42.96 Million | 28.31 Million | 26.97 Million | 27.64 Million |
| Interest Expense | 624.39 Thousand | 211.18 Thousand | 248.88 Thousand | 299.89 Thousand |
| Income Tax Expense | 2.48 Million | 2.01 Million | 1.7 Million | 1.68 Million |
| Earnings before Tax | 55.57 Million | 28.93 Million | 27.52 Million | 28.33 Million |
| Net Income | 52.38 Million | 26.92 Million | 25.82 Million | 26.65 Million |
| Earnings Per Share Basic | 4.99 | 2.56 | 2.46 | 2.54 |
| Earnings Per Share Diluted | 4.99 | 2.56 | 2.46 | 2.54 |
| Weighted Average Shares Outstanding | 10.5 Million | 10.5 Million | 10.5 Million | 10.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.5 Million | 10.5 Million | 10.5 Million | 10.5 Million |
| Gross Margin | 0.40 | 0.40 | 0.40 | 0.40 |
| EBIT Margin | 0.36 | 0.28 | 0.29 | 0.29 |
| Profit Margin | 0.29 | 0.21 | 0.22 | 0.23 |
| EBITDA | 65.27 Million | 36.03 Million | 33.89 Million | 34.72 Million |
| Earnings Before Tax Margin | 0.24 | 0.22 | 0.23 | 0.24 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 48.13 Million | 48.13 Million | 182.35 Million | 50.25 Million | 50.25 Million | 81.84 Million |
| Cost of Revenue | 32.37 Million | 32.37 Million | 108.58 Million | 31.18 Million | 31.18 Million | 48.2 Million |
| Gross Profit | 15.76 Million | 15.76 Million | 73.76 Million | 19.07 Million | 19.07 Million | 33.63 Million |
| Operating Expenses | 8.42 Million | 8.42 Million | 30.18 Million | 6.91 Million | 6.03 Million | 14.97 Million |
| Selling, General and Administrative Expenses | 8.42 Million | 8.42 Million | - | 6.48 Million | 6.48 Million | 14.97 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 1.00 | 1.00 | 3.57 Million | 437.73 Thousand | - | - |
| Cost and Expenses | 40.79 Million | 40.79 Million | 138.77 Million | 38.1 Million | 37.21 Million | 63.18 Million |
| Operating Income | 7.34 Million | 7.34 Million | 43.58 Million | 12.15 Million | 12.59 Million | 18.65 Million |
| Interest Expense | - | - | 624.39 Thousand | - | - | 528.95 Thousand |
| Income Tax Expense | 731.22 Thousand | 731.22 Thousand | 2.48 Million | 665.49 Thousand | 665.49 Thousand | 1.14 Million |
| Earnings before Tax | 7.25 Million | 7.25 Million | 55.57 Million | 12.97 Million | 12.97 Million | 29.22 Million |
| Net Income | 6.52 Million | 6.52 Million | 52.38 Million | 12.3 Million | 12.3 Million | 27.76 Million |
| Earnings Per Share Basic | 0.62 | 0.62 | - | 1.17 | 1.17 | 2.64 |
| Earnings Per Share Diluted | 0.62 | 0.62 | - | 1.17 | 1.17 | 2.64 |
| Weighted Average Shares Outstanding | 10.5 Million | 10.5 Million | 10.5 Million | 10.5 Million | 10.5 Million | 10.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.5 Million | 10.5 Million | 10.5 Million | 10.5 Million | 10.5 Million | 10.5 Million |
| Gross Margin | 0.33 | 0.33 | 0.40 | 0.38 | 0.38 | 0.41 |
| EBIT Margin | 0.20 | 0.20 | - | 0.29 | 0.29 | 0.29 |
| Profit Margin | 0.14 | 0.14 | 0.29 | 0.24 | 0.24 | 0.34 |
| EBITDA | 9.7 Million | 9.7 Million | - | 14.48 Million | 14.48 Million | 23.46 Million |
| Earnings Before Tax Margin | 0.15 | 0.15 | 0.24 | 0.24 | 0.25 | 0.23 |
MTTCF
RDRB
REDTAPE
1382
600531
CHENNPETRO